MURAL - Maynooth University Research Archive Library

    Repurposing without purpose? Early innovation responses to the COVID-19 crisis: Evidence from clinical trials

    Hanisch, Marvin and Rake, Bastian (2021) Repurposing without purpose? Early innovation responses to the COVID-19 crisis: Evidence from clinical trials. R&D Management, 51 (4). pp. 393-409. ISSN 1467-9310

    Download (740kB) | Preview

    Share your research

    Twitter Facebook LinkedIn GooglePlus Email more...

    Add this article to your Mendeley library


    The novel coronavirus has created one of the biggest social and economic challenges in recent decades. Since a critical issue in overcoming a large-scale pandemic involves finding effective treatments for the disease, there is typically urgent pressure on the health-care sector to develop innovations to combat the pandemic. Recently, scholars have argued that repurposing – that is, reusing an existing innovation in a different context – allows for such rapid innovation responses and can reduce costs, as the groundwork has already been laid. In this paper, we compare these benefits with the considerable disadvantages associated with innovation repurposing, including lowered barriers to entry, which can lead to declining average quality and duplicate work. Using data on 2,456 COVID-19-related clinical trials initiated between December 2019 and July 2020, we find that merely one-third of the trials actually investigated drugs or vaccines, whereas the rest focused on diagnostics and crisis management issues. In the trials concerning drug testing, we find that drug repurposing is a predominant innovation strategy, but many trials tested the same (combination of) drugs. This indicates an inefficient use of resources and reductions in the average variety and novelty of clinical trials. Furthermore, the small percentage of biopharmaceutical firms involved in the search for COVID-19 treatments raises the question of whether firms may have insufficient incentives to redirect innovation efforts to respond to the pandemic. Our paper contributes to crisis management research, the nascent debate on COVID-19, and the emerging literature on innovation repurposing.

    Item Type: Article
    Keywords: repurposing; purpose; early innovation responses; covid 19; evidence; clinical trials;
    Academic Unit: Faculty of Social Sciences > School of Business
    Item ID: 18251
    Depositing User: Bastian Rake
    Date Deposited: 06 Mar 2024 16:03
    Journal or Publication Title: R&D Management
    Publisher: Blackwell Publishing
    Refereed: Yes
    Use Licence: This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

    Repository Staff Only(login required)

    View Item Item control page


    Downloads per month over past year

    Origin of downloads